High drug costs can lead to people skipping their prescriptions. This can lead to many serious adverse drug effects to include withdrawal akathisia. Read the full article here.

Two new lawsuits charge many patients taking a Gilead HIV drug “needlessly suffered debilitating and sometimes fatal kidney and bone damage as well as damage to their teeth.” Read the full article here.

MISSD can’t help but be thrilled with these new analytics: More than 11.9K new views to our YouTube Channel in less than 90 days. Viewers from across the globe include India, USA, Saudi Arabia, Canada…

We are grateful to all who help us increase awareness of adverse drug effects.

Sixty two percent of this specific drug class received the FDA’s most stringent warning, known as a “black box.” Most of the serious adverse effects were identified only after the drugs were on the market.

 “It raises the question of should we be regulating them differently,” said Joseph Ross, an associate professor of medicine at Yale School of Medicine, who has studied drug safety. Read the full article here.

Experts by experience is a term increasingly used to describe healthcare consumers and their families who share factual, first-hand experiences relating to pharmaceutical products and doctors’ care.  Gail Regenbogen, a MISSD board member, discusses her late husband, Howard’s, prescribed demise in our second  Akathisia Stories podcast.

Please listen and share so that others can be safer and better informed regarding critical adverse drug effects. Gail eloquently tells her family’s story with profound wisdom acquired after Howard’s akathisia-induced death. Listen here.

MISSD is thrilled to reach 500 FB likes today. But even better is that our new Akathisia Awareness ads are taking off on many new Chicago train lines.  Way to roll!

Hundreds of doctors learned more about akathisia during MISSD’s recent presentation at the Royal College of Psychiatrists’ International Congress. Wendy Dolin shared case studies and MISSD videos that highlight the external and internal symptoms doctors should look for when assessing for akathisia.

The power of sharing lived experiences is key to creating positive changes in health care. MISSD is pleased to release our first podcast in a series called “Akathisia Stories.” Please listen, learn & share here.

A recent study published in the JAMA Internal Medicine journal suggests the risk for dementia is strongest for certain classes of anticholinergic drugs — particularly antidepressants, bladder antimuscarinics, antipsychotics and antiepileptic drugs.

For the full article, click here.

It’s often difficult for pregnant or breastfeeding women to obtain data regarding the safe use of prescription drugs, particularly given it can take more than 20 years to collect reliable safety info on drugs after they come to market. An international effort is underway to improve information in this critical area.

To read the full article, click here.